Cholestyramine: Difference between revisions

Jump to navigation Jump to search
No edit summary
Line 50: Line 50:




[[{{PAGENAME}}#Publication Resources|Publication Resources]]
 
<br><small>Recent articles, WikiDoc State of the Art Review, Textbook Information</small><font size="4"><br>
'''  [[{{PAGENAME}}#Publication Resources|Publication Resources]]<small>Recent articles, WikiDoc State of the Art Review, Textbook Information</small><font size="4">'''
[[{{PAGENAME}}#Media Resources|Media Resources]]
'''| [[{{PAGENAME}}#Media Resources|Media Resources]]</font size><small>Slides, Video, Images, MP3, Podcasts, etc.</small><font size="4">'''
<br></font size><small>Slides, Video, Images, MP3, Podcasts, etc.</small><font size="4"><br><br>
'''| [[{{PAGENAME}}#International Resources|International Resources]]</font size><small>en Español</small><font size="4"><br>'''
[[{{PAGENAME}}#Patient Resources|Patient Resources]]
<br></font size><small>Discussion Groups, Handouts, Blogs, News, etc.</small><font size="4"><br>
[[{{PAGENAME}}#International Resources|International Resources]]
<br></font size><small>en Español</small><font size="4"><br>


</div></div>
</div></div>

Revision as of 21:40, 10 February 2014


Cholestyramine
PREVALITE® FDA Package Insert
Indications and Usage
Dosage and Administration
Dosage Forms and Strengths
Contraindications
Warnings and Precautions
Adverse Reactions
Drug Interactions
Use in Specific Populations
Overdosage
Description
Clinical Pharmacology
Nonclinical Toxicology
Clinical Studies
How Supplied/Storage and Handling
Patient Counseling Information
Labels and Packages
Clinical Trials on Cholestyramine
ClinicalTrials.gov

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Sheng Shi, M.D. [2]

For patient information about Cholestyramine, click here.

Synonyms / Brand Names: PREVALITE®

Overview

Cholestyramine or colestyramine (PREVALITE, CHOLESTYRAMINE,CHOLESTYRAMINE LIGHT) is a bile acid sequestrant, which binds bile in the gastrointestinal tract to prevent its reabsorption. It is a strong ion exchange resin, which means that it can exchange its chloride anions with anionic bile acids in the gastrointestinal tract and bind them strongly in the resin matrix. The functional group of the anion exchange resin is a quaternary ammonium group attached to an inert styrene-divinylbenzene copolymer.

Cholestyramine removes bile acids from the body by forming insoluble complexes with bile acids in the intestine, which are then excreted in the feces. When bile acids are excreted, plasma cholesterol is converted to bile acid to normalize bile acid levels. This conversion of cholesterol into bile acids lowers plasma cholesterol levels.


Category

FDA Package Insert

Indications and Usage | Dosage and Administration | Dosage Forms and Strengths | Contraindications | Warnings and Precautions | Adverse Reactions | Drug Interactions | Use in Specific Populations | Overdosage | Description | Clinical Pharmacology | Nonclinical Toxicology | Clinical Studies | How Supplied/Storage and Handling | Patient Counseling Information | Labels and Packages

Mechanism of Action

Cholestyramine belongs to the Bile acid sequestrants.Bile acid sequestrants are polymeric compounds that serve as ion-exchange resins. Bile acid sequestrants exchange anions such as chloride ions for bile acids. By doing so, they bind bile acids and sequester them from enterohepatic circulation. Since bile acid sequesterants are large polymeric structures, they are not well-absorbed from the gut into the bloodstream. Thus, bile acid sequestrants, along with any bile acids bound to the drug, are excreted via the feces after passage through the gastrointestinal tract.[1]


External Links


Publication ResourcesRecent articles, WikiDoc State of the Art Review, Textbook Information | Media ResourcesSlides, Video, Images, MP3, Podcasts, etc. | International Resourcesen Español

References

Template:Lipid modifying agents